Systemic griseofulvin therapy of monilethrix.
After a report of clinical effectiveness, four adult patients with monilethrix were treated with griseofulvin for six months at an orally administered dose of 500 mg (microsize) per day. No objective or subjective improvement was observed.
D000293:Adolescent; D000328:Adult; D005260:Female; D006118:Griseofulvin / Q000627:therapeutic use*; D006197:Hair; D006801:Humans; D008297:Male; D012871:Skin Diseases / Q000188:drug therapy
D006118:Griseofulvin